April 5, 2024 — The Cardiovascular Research Foundation (CRF) is pleased to introduce New York Valve: Structural Heart Summit, an expansion of the renowned Transcatheter Valve Therapy (TVT) annual conference. The new summit, to be held June 5-7, 2024 at the Jacob K. Javits Convention Center in New York City North, will be a world-class educational experience in the field of structural cardiac interventions.

“New York Valves 2024 represents a significant milestone for our organization,” said Juan F. Granada, M.D., CRF President and CEO and New York Valves Program Director. said. “For the first time, this conference will provide a unique interactive environment for networking, collaboration, and education that includes all cardiac team members. It will provide professionals with the latest developments in each specific area of ​​our field. “Through real-world multidisciplinary collaboration, this summit will not only advance our knowledge but also directly impact patient care around the world.”

For nearly 20 years, CRF has pioneered and led the way in transcatheter treatment of structural heart disease in TVT. New York Valves celebrates the next iteration of this tradition, featuring three days of his innovative research and techniques that are redefining the landscape of structural cardiac interventions. This is the premier gathering of interventional cardiologists, cardiac surgeons, clinical cardiologists, cardiac imagers, heart failure specialists, and other cardiac team members under one roof. New York Valves has renewed its emphasis on interdisciplinary collaboration, bringing together all specialties to develop the most effective, personalized treatment strategies for patients with valvular heart disease and structural heart disease. provides participants with the opportunity to tap into the expertise of

“New York Valve 2024 is more than just a meeting. It is a multidisciplinary movement that is reshaping the landscape of cardiovascular care in patients with valvular disease and structural heart disease,” said CRF Founder and President Emeritus and New York Valve Chair. said program director Martin B. Leon, MD. “From new treatments to best clinical practices, this summit represents the evolution of transcatheter treatments and surgical interventions. Our goal is to unite experts from all areas of cardiovascular care. , to expand our cardiac team, redefine innovation and develop new standards for managing valve patients.”

Transcatheter valve therapy has evolved from a new treatment for the sickest patients to become the standard of care for many patients with aortic stenosis. The rapid introduction of transcatheter mitral and tricuspid valve therapy has also transformed the treatment landscape and expanded options for patients with structural heart disease.

New York Valves 2024 will showcase advanced technology and evidence-based medicine through live case demonstrations, hands-on training, lively discussions, and the latest updates to bring knowledge to the field. Featuring an impressive lineup of world-renowned experts, this comprehensive program delves into best practices, clinical decision making, patient selection, and strategies for equipment, imaging, procedures, and complication management. , is designed as a practical case-based course. . The summit will also highlight the latest advances and research in the field, providing attendees with an unparalleled opportunity to explore the latest techniques and techniques in structural cardiac interventions.

For more information, please visit www.crf.org.